澳大利亚2008-2018年动脉瘤性蛛网膜下腔出血发病率与病死率
该回顾性横断面研究基于澳大利亚全国医院发病率数据库,纳入2008至2018年共12915例aSAH住院病例。研究发现aSAH年发病率保持稳定(平均5.5例/10万人年,范围5.3-6.0),30天病死率26.7%且每年约下降0.7%(P<0.0001)。
要点
- aSAH发病率未下降,年均5.5例/10万人年。
- 30天病死率26.7%,每年约下降0.7%。
- 高龄、脑内或脑室内出血、高血压预示不良结局。
核心结论
- 2008至2018年澳大利亚aSAH发病率未下降,但30天病死率下降。
研究设计与样本
- 回顾性横断面研究,数据来自澳大利亚全国医院发病率数据库2008-2018年全部aSAH住院病例,共12915例。
主要发现
- 年发病率保持稳定,平均5.5例/10万人年(范围5.3-6.0)。
- 总体aSAH相关30天病死率为26.7%,每年约下降0.7%(P<0.0001)。
- 40岁后每增加5岁,年龄调整发病率增加1.3例/10万人年。
- 血管内治疗占总体治疗策略的63.1%。
- 高龄(P<0.0001)、脑内或脑室内出血(P<0.0001)、高血压(P=0.0007)为不良结局的显著预测因素。
临床怎么用
- 提示澳大利亚aSAH疾病负担未减,但短期病死率改善,可辅助评估救治体系效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contemporary aneurysmal subarachnoid hemorrhage (aSAH) and case-fatality studies have suggested a diminishing worldwide incidence. The purpose of this study was to examine whether such epidemiologic trends occur in Australia. METHODS: This retrospective cross-sectional study was based on data retrieved from the Nationwide Hospital Morbidity Database for all aSAH cases across hospital networks in Australia between 2008 and 2018. Information on patient characteristics, aneurysm location, procedures performed, and discharge disposition were extracted. We estimated the crude and age-adjusted incidences, trends of aSAH, and case fatality rate over time. Putative risk factors were investigated with univariate and multivariate logistic regression analysis to identify independent predictors of unfavorable discharge outcome (death and dependency). RESULTS: A total of 12,915 acute hospital admissions with aSAH were identified. Annual aSAH rate remained stable (mean 5.5, range 5.3-6.0 cases per 100,000 person-years) with no decline. The overall aSAH-associated 30-day case-fatality rate was 26.7% of admissions and declined by approximately 0.7% annually (P < 0.0001). Age-adjusted incidence increased with advancing age at increments of 1.3 cases per 100,000 person-years for each 5 years after the age of 40 years. Endovascular therapy accounted for 63.1% of the overall treatment strategy. Logistic regression demonstrated older age (P < 0.0001), presence of intracerebral or intraventricular hemorrhage (P < 0.0001), and hypertension (P = 0.0007) were significant predictors of unfavorable outcome. CONCLUSIONS: A decline in 30-day case-fatality rate but not aSAH incidence from 2008 to 2018 was observed.
引用
- Huang H, Lai LT. Incidence and Case-Fatality of Aneurysmal Subarachnoid Hemorrhage in Australia, 2008-2018. World Neurosurg. 2020. PMID: 32889187. doi:10.1016/j.wneu.2020.08.186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。